Radiopharmaceuticals Market Analysis APAC, North America, Europe, Middle East and Africa, South America - US, China, Japan, South Korea, Germany - Size and Forecast 2023-2027

Published: Oct 2023

Pages: 160

SKU: IRTNTR43963

Snapshot

Radiopharmaceuticals Market Report 2023-2027:

The global radiopharmaceuticals market size is estimated to grow by USD 4,612.62 million at a CAGR of 10.22% between 2022 and 2027.

Radiopharmaceuticals have fewer side effects as compared with their potential benefits. This is a crucial factor in determining the use of medicinal products for different diagnostics and treatment purposes. Presently, there are no known long-term side effects of low-dose exposure to radiopharmaceuticals. Radiopharmaceuticals may cause some health hazards, such as soreness, bleeding, and swelling at the site of injection, but these are quite rarely observed. The low rates of unfavorable effects of radiopharmaceuticals are mainly due to the small amount of the drug used during the various processes.

Technavio has segmented the market into Source, End-user, and Geography

The source is classified into cyclotrons and nuclear reactors
The end-user is classified into diagnostics and therapeutics
The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the size of the Radiopharmaceuticals Market During the Forecast Period?

To learn more about this report, Request Free Sample

Radiopharmaceuticals Market Segmentation by Source, End-user, and Geography

Source Analysis

Cyclotrons

The market share growth by the cyclotrons segment will be significant during the forecast period. Cyclotron is a type of particle accelerator, a machine that uses electromagnetic fields to propel charged particles to very high speeds and energies. It produces radioisotopes for a specific type of medicinal product known as radiopharmaceuticals, which are very common in the diagnosis and treatment of cancer.

Get a glance at the market contribution of various segments View a PDF Sample

The cyclotrons segment was valued at USD 3,381.05 million in 2017. Cyclotrons are rapidly developing and play an important role in the healthcare sector, the radiopharmaceuticals produced from cyclotrons are very efficient at detecting various cancers, especially in advanced medical imaging. Therefore, a few factors will drive the growth of the cyclotrons segment in the global radiopharmaceuticals market during the forecast period.

End-user Analysis

Diagnostics

Diagnostic medical imaging is an essential part of modern healthcare services. Diagnostics, specifically medical imaging, have completely revolutionized the healthcare industry in the past few decades and hence, allowed doctors to detect disease earlier and improve the outcome. The use of radiopharmaceuticals for medical imaging to provide a body view is a non-invasive method. A large number of benefits associated with accurate diagnosis have led to higher demand for new diagnostic techniques. On a chemical level, each organ of the body is reacting in different ways. Chemists and doctors have identified various chemicals that get absorbed by specific organs. The diagnostics segment is expected to grow in the global radiopharmaceuticals market during the forecast period.

Therapeutics

Radiopharmaceuticals can be used to treat various diseases, such as blood disorders, hyperthyroidism, and several types of cancers. Radioisotopes that emit short-range particles (beta or alpha) are used for the therapy. These radioisotopes lose their energy over a short distance, hence causing a lot of local damage, such as cell damage. It may be used to treat a number of diseases, e.g. cancer cell destruction, and pain management in patients undergoing palliative care for arthritis or osteosarcoma. The radiopharmaceutical therapeutics market has a high growth rate and is poised for greater growth and development during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America dominated the global radiopharmaceuticals market, mainly due to rising investment in R&D activities in the healthcare industry, especially in the US market. The significant growth in the radiopharmaceutical market has been stimulated by the increasing use of diagnostics for complete disease diagnosis.

Also, the proven efficacy of early and optimum detection of even chronic diseases such as cancer has led to the high popularity of these diagnostics, which use radioisotopes extensively. Apart from cancer, other disorders such as thyroid and cardiology are also finding the usage of radiopharmaceuticals which will lead to higher demand for radiopharmaceutical drugs in the region. However, the expected shutdown of nuclear reactors. Such factors will increase the market growth in this region during the forecast period.

COVID Recovery Analysis

In 2020, the outbreak of COVID-19 adversely affected all countries in North America, especially the US. However, in the first half of 2021, the COVID-19-induced lockdown restrictions were lifted owing to the large-scale vaccination drives that were conducted by the governments across the region. This rise in the demand for radiopharmaceuticals has been felt throughout the region due to this resumption of postponed operations. Furthermore, the rise in the number of diagnostic laboratories will increase the demand for radiopharmaceuticals in the region. Therefore, the radiopharmaceuticals market in the region will grow significantly during the forecast period.

Buy Now Full Report and Discover More

Key Radiopharmaceuticals Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Bayer AG- The company offers radiopharmaceuticals such as Ultravist, MEDRAD and contrast dose management.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Radiopharmaceuticals Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.

Key Radiopharmaceuticals Market Drivers

The rising incidence of neurological disorders is driving growth in the radiopharmaceutical market. Neurological disorders relate to the brain, spinal, and nerves. Neurological disorders pose a great threat to public health. Neurological disorders and their outcome are estimated to affect an immense number of people globally. These disorders are found globally irrespective of age group, gender, race, and geographical region.

Radiopharmaceuticals play a significant role in the treatment and diagnostics of neurological disorders. Hence, more demand for radiopharmaceuticals will arise from an increase in the prevalence of neural disorders and their significant societal burden. Therefore, the rising incidence of neurological disorders will drive the growth of the global radiopharmaceuticals market during the forecast period.

Significant Radiopharmaceuticals Market Trends

Production of cyclotron-based radiopharmaceuticals is a key trend in the radiopharmaceutical market. Due to a shortage of radiopharmaceuticals produced in reactors, discussions are being held about the production of these isotopes using different methods. Cyclotrons allow the production of hospital-based radiopharmaceuticals.

In addition, cyclotrons offer various advantages, such as safety, low operating costs, and low waste generation. Thus, the demand for radioisotopes made from cyclotrons is enormous. The factors such as the production of cyclotron-based radiopharmaceuticals are expected to surge the growth of the global radiopharmaceuticals market during the forecast period.

Major Radiopharmaceuticals Market Challenges

The regulatory hurdles regarding the preparation of radiopharmaceuticals are a major challenge in the radiopharmaceutical market. In the US, an investigational approach to the approval of new radiopharmaceuticals has been developed by the FDA and the American College of Radiology Imaging Network, comparing a new drug with a standard molecule. Owing to extensive toxicology testing, the radiopharmaceutical compound undergoes additional scrutiny and approval pathway.

Moreover, the transportation of radioactive materials is also expensive, which has restricted the distribution of PET in Japan. The entry of new players into the market can be prevented by restrictive rules and the high cost of transporting radiopharmaceuticals, which could lead to a threat to developments in the Radiopharmaceutical Market. Therefore, the regulatory hurdles regarding the preparation of radiopharmaceuticals will hinder the growth of the global pharmaceuticals market during the forecast period.

Buy Now Full Report and Discover More

Key Radiopharmaceuticals Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Radiopharmaceuticals Market Customer Landscape

Segment Overview

The radiopharmaceuticals market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

Source Outlook (USD Million, 2017 - 2027)
- Cyclotrons
- Nuclear reactors

End-user Outlook (USD Million, 2017 - 2027)
- Diagnostics
- Therapeutics

Region Outlook (USD Million, 2017 - 2027)
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- APAC
  - China
  - India
- ROW
  - Australia
  - Argentina
  - Rest of the World

Radiopharmaceuticals Market Scope
Report Coverage	Details
Page number	160
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 10.22%
Market growth 2023-2027	USD 4,612.62 million
Market structure	Fragmented
YoY growth 2022-2023(%)	10.02
Regional analysis	North America, Europe, Asia, and the Rest of the World (ROW)
Performing market contribution	North America at 42%
Key countries	US, Canada, China, Germany, and the UK
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Bayer AG, Bracco Spa, Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, General Electric Co., IBA Radiopharma Solutions, Jubilant Pharma Ltd., Lantheus Holdings Inc., Mallinckrodt Plc, NorthStar Medical Radioisotopes LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Positron Corp., Radiomedix Inc., Siemens AG, Sinotau Pharmaceuticals, Telix Pharmaceuticals Ltd., and Sotera Health Co.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Radiopharmaceuticals Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the Radiopharmaceuticals Market between 2023 and 2027
Precise estimation of the size of the radiopharmaceuticals market size and its contribution to the market in focus on the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies' position and classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of radiopharmaceuticals market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Source
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global radiopharmaceuticals market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on global radiopharmaceuticals market 2017 - 2021 ($ million)

4.2 Source Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Source Segment 2017 - 2021 ($ million)

4.3 End-user Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Source

6.1 Market segments
- Exhibit 30: Chart on Source - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Source - Market share 2022-2027 (%)

6.2 Comparison by Source
- Exhibit 32: Chart on Comparison by Source
- Exhibit 33: Data Table on Comparison by Source

6.3 Cyclotrons - Market size and forecast 2022-2027
- Exhibit 34: Chart on Cyclotrons - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Cyclotrons - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Cyclotrons - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Cyclotrons - Year-over-year growth 2022-2027 (%)

6.4 Nuclear reactors - Market size and forecast 2022-2027
- Exhibit 38: Chart on Nuclear reactors - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Nuclear reactors - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Nuclear reactors - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Nuclear reactors - Year-over-year growth 2022-2027 (%)

6.5 Market opportunity by Source
- Exhibit 42: Market opportunity by Source ($ million)
- Exhibit 43: Data Table on Market opportunity by Source ($ million)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)

7.2 Comparison by End-user
- Exhibit 46: Chart on Comparison by End-user
- Exhibit 47: Data Table on Comparison by End-user

7.3 Diagnostics - Market size and forecast 2022-2027
- Exhibit 48: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)

7.4 Therapeutics - Market size and forecast 2022-2027
- Exhibit 52: Chart on Therapeutics - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Therapeutics - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Therapeutics - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Therapeutics - Year-over-year growth 2022-2027 (%)

7.5 Market opportunity by End-user
- Exhibit 56: Market opportunity by End-user ($ million)
- Exhibit 57: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2022-2027 (%)
- Exhibit 60: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027
- Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027
- Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027
- Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027
- Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 Germany - Market size and forecast 2022-2027
- Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.9 UK - Market size and forecast 2022-2027
- Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.10 Canada - Market size and forecast 2022-2027
- Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)

9.11 China - Market size and forecast 2022-2027
- Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ million)
- Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption

11.4 Industry risks
- Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 105: Vendors covered

12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification

12.3 Bayer AG
- Exhibit 107: Bayer AG - Overview
- Exhibit 108: Bayer AG - Business segments
- Exhibit 109: Bayer AG - Key news
- Exhibit 110: Bayer AG - Key offerings
- Exhibit 111: Bayer AG - Segment focus

12.4 Bracco Spa
- Exhibit 112: Bracco Spa - Overview
- Exhibit 113: Bracco Spa - Product / Service
- Exhibit 114: Bracco Spa - Key offerings

12.5 Cardinal Health Inc.
- Exhibit 115: Cardinal Health Inc. - Overview
- Exhibit 116: Cardinal Health Inc. - Business segments
- Exhibit 117: Cardinal Health Inc. - Key news
- Exhibit 118: Cardinal Health Inc. - Key offerings
- Exhibit 119: Cardinal Health Inc. - Segment focus

12.6 Curium Pharma
- Exhibit 120: Curium Pharma - Overview
- Exhibit 121: Curium Pharma - Product / Service
- Exhibit 122: Curium Pharma - Key offerings

12.7 Eckert and Ziegler AG
- Exhibit 123: Eckert and Ziegler AG - Overview
- Exhibit 124: Eckert and Ziegler AG - Business segments
- Exhibit 125: Eckert and Ziegler AG - Key news
- Exhibit 126: Eckert and Ziegler AG - Key offerings
- Exhibit 127: Eckert and Ziegler AG - Segment focus

12.8 General Electric Co.
- Exhibit 128: General Electric Co. - Overview
- Exhibit 129: General Electric Co. - Business segments
- Exhibit 130: General Electric Co. - Key news
- Exhibit 131: General Electric Co. - Key offerings
- Exhibit 132: General Electric Co. - Segment focus

12.9 IBA Radiopharma Solutions
- Exhibit 133: IBA Radiopharma Solutions - Overview
- Exhibit 134: IBA Radiopharma Solutions - Business segments
- Exhibit 135: IBA Radiopharma Solutions - Key offerings
- Exhibit 136: IBA Radiopharma Solutions - Segment focus

12.10 Jubilant Pharma Ltd.
- Exhibit 137: Jubilant Pharma Ltd. - Overview
- Exhibit 138: Jubilant Pharma Ltd. - Product / Service
- Exhibit 139: Jubilant Pharma Ltd. - Key offerings

12.11 Lantheus Holdings Inc.
- Exhibit 140: Lantheus Holdings Inc. - Overview
- Exhibit 141: Lantheus Holdings Inc. - Business segments
- Exhibit 142: Lantheus Holdings Inc. - Key offerings
- Exhibit 143: Lantheus Holdings Inc. - Segment focus

12.12 NorthStar Medical Radioisotopes LLC
- Exhibit 144: NorthStar Medical Radioisotopes LLC - Overview
- Exhibit 145: NorthStar Medical Radioisotopes LLC - Product / Service
- Exhibit 146: NorthStar Medical Radioisotopes LLC - Key offerings

12.13 Novartis AG
- Exhibit 147: Novartis AG - Overview
- Exhibit 148: Novartis AG - Business segments
- Exhibit 149: Novartis AG - Key offerings
- Exhibit 150: Novartis AG - Segment focus

12.14 NTP Radioisotopes SOC Ltd.
- Exhibit 151: NTP Radioisotopes SOC Ltd. - Overview
- Exhibit 152: NTP Radioisotopes SOC Ltd. - Product / Service
- Exhibit 153: NTP Radioisotopes SOC Ltd. - Key offerings

12.15 PharmaLogic Holdings Corp.
- Exhibit 154: PharmaLogic Holdings Corp. - Overview
- Exhibit 155: PharmaLogic Holdings Corp. - Product / Service
- Exhibit 156: PharmaLogic Holdings Corp. - Key offerings

12.16 Siemens AG
- Exhibit 157: Siemens AG - Overview
- Exhibit 158: Siemens AG - Business segments
- Exhibit 159: Siemens AG - Key news
- Exhibit 160: Siemens AG - Key offerings
- Exhibit 161: Siemens AG - Segment focus

12.17 Sotera Health Co.
- Exhibit 162: Sotera Health Co. - Overview
- Exhibit 163: Sotera Health Co. - Business segments
- Exhibit 164: Sotera Health Co. - Key offerings
- Exhibit 165: Sotera Health Co. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 166: Inclusions checklist
- Exhibit 167: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 168: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 169: Research methodology
- Exhibit 170: Validation techniques employed for market sizing
- Exhibit 171: Information sources

13.5 List of abbreviations
- Exhibit 172: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

radiopharmaceuticals market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis